TrialMolecular oncology2016

Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastoma.

Jennifer R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.